{"entity":{"type":"insider","cik":"0001898490","url":"/insider/0001898490","json_url":"/insider/0001898490.json","name":"Farnum Rhonda","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":16,"first":"2022-03-02","last":"2026-06-17","span_basis":"filed_date"},"name_variants":[{"name":"Farnum Rhonda","source":"filing","n_filings":16,"first_seen":"2022-03-02","last_seen":"2026-06-17"}],"transactions":[{"id":6083100,"accession":"0001898490-26-000010","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001898490-26-000010","line_url":"/filing/0001898490-26-000010","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001898490","owner_name":"Farnum Rhonda","owner_display_name":"Farnum Rhonda","owner_url":"/insider/0001898490","role":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark":"O","role_mark_label":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, COMM & MEDICAL AFFAIRS","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13314.0,"shares_display":"13,314","price_per_share":16.386300240348504,"price_display":"16.39","price_state":"stated","total_value":218167.2014,"total_display":"218,167.20","total_whole":"218,167","shares_owned_after":232457.0,"shares_owned_after_display":"232,457","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-17","scope":"insider","n_lines":3},{"id":6120949,"accession":"0001898490-26-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001898490-26-000004","line_url":"/filing/0001898490-26-000004","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001898490","owner_name":"Farnum Rhonda","owner_display_name":"Farnum Rhonda","owner_url":"/insider/0001898490","role":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark":"O","role_mark_label":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, COMM & MEDICAL AFFAIRS","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31067.0,"shares_display":"31,067","price_per_share":13.958126349502688,"price_display":"13.96","price_state":"stated","total_value":433637.1113,"total_display":"433,637.11","total_whole":"433,637","shares_owned_after":240465.0,"shares_owned_after_display":"240,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-18","scope":"insider","n_lines":3},{"id":4054133,"accession":"0001898490-25-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001898490-25-000008","line_url":"/filing/0001898490-25-000008","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001898490","owner_name":"Farnum Rhonda","owner_display_name":"Farnum Rhonda","owner_url":"/insider/0001898490","role":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark":"O","role_mark_label":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, COMM & MEDICAL AFFAIRS","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31067.0,"shares_display":"31,067","price_per_share":18.749824968616217,"price_display":"18.75","price_state":"stated","total_value":582500.8123,"total_display":"582,500.81","total_whole":"582,501","shares_owned_after":277695.0,"shares_owned_after_display":"277,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-03","filed_date":"2025-12-05","scope":"insider","n_lines":3},{"id":4075067,"accession":"0001415889-25-019869","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-019869","line_url":"/filing/0001415889-25-019869","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001898490","owner_name":"Farnum Rhonda","owner_display_name":"Farnum Rhonda","owner_url":"/insider/0001898490","role":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark":"O","role_mark_label":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, COMM & MEDICAL AFFAIRS","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":11.38695104,"price_display":"11.39","price_state":"stated","total_value":113869.5104,"total_display":"113,869.51","total_whole":"113,870","shares_owned_after":330918.0,"shares_owned_after_display":"330,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-14","filed_date":"2025-07-16","scope":"insider","n_lines":3},{"id":4245653,"accession":"0001415889-25-015642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-015642","line_url":"/filing/0001415889-25-015642#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001898490","owner_name":"Farnum Rhonda","owner_display_name":"Farnum Rhonda","owner_url":"/insider/0001898490","role":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark":"O","role_mark_label":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, COMM & MEDICAL AFFAIRS","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":264000.0,"total_display":"264,000.00","total_whole":"264,000","shares_owned_after":336918.0,"shares_owned_after_display":"336,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-02","filed_date":"2025-06-04","scope":"insider"},{"id":4952351,"accession":"0001415889-25-011227","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-011227","line_url":"/filing/0001415889-25-011227#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001898490","owner_name":"Farnum Rhonda","owner_display_name":"Farnum Rhonda","owner_url":"/insider/0001898490","role":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark":"O","role_mark_label":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, COMM & MEDICAL AFFAIRS","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":36000.0,"total_display":"36,000.00","total_whole":"36,000","shares_owned_after":370038.0,"shares_owned_after_display":"370,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-21","filed_date":"2025-04-23","scope":"insider"},{"id":4555230,"accession":"0001415889-25-001957","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-001957","line_url":"/filing/0001415889-25-001957#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001898490","owner_name":"Farnum Rhonda","owner_display_name":"Farnum Rhonda","owner_url":"/insider/0001898490","role":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark":"O","role_mark_label":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, COMM & MEDICAL AFFAIRS","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":36000.0,"total_display":"36,000.00","total_whole":"36,000","shares_owned_after":309565.0,"shares_owned_after_display":"309,565","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-23","scope":"insider"},{"id":2662645,"accession":"0001415889-24-026766","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-026766","line_url":"/filing/0001415889-24-026766#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001898490","owner_name":"Farnum Rhonda","owner_display_name":"Farnum Rhonda","owner_url":"/insider/0001898490","role":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark":"O","role_mark_label":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, COMM & MEDICAL AFFAIRS","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":36000.0,"total_display":"36,000.00","total_whole":"36,000","shares_owned_after":322743.0,"shares_owned_after_display":"322,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-13","scope":"insider"},{"id":2530433,"accession":"0001415889-24-019534","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-019534","line_url":"/filing/0001415889-24-019534#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001898490","owner_name":"Farnum Rhonda","owner_display_name":"Farnum Rhonda","owner_url":"/insider/0001898490","role":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark":"O","role_mark_label":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, COMM & MEDICAL AFFAIRS","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":36000.0,"total_display":"36,000.00","total_whole":"36,000","shares_owned_after":335965.0,"shares_owned_after_display":"335,965","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-10","filed_date":"2024-07-12","scope":"insider"},{"id":2521978,"accession":"0001415889-24-004958","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-004958","line_url":"/filing/0001415889-24-004958#line-2","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001898490","owner_name":"Farnum Rhonda","owner_display_name":"Farnum Rhonda","owner_url":"/insider/0001898490","role":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark":"O","role_mark_label":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, COMM & MEDICAL AFFAIRS","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1254.0,"shares_display":"1,254","price_per_share":8.71,"price_display":"8.71","price_state":"stated","total_value":10922.34,"total_display":"10,922.34","total_whole":"10,922","shares_owned_after":311733.0,"shares_owned_after_display":"311,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-22","filed_date":"2024-02-22","scope":"insider"},{"id":8263084,"accession":"0001415889-23-015446","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-015446","line_url":"/filing/0001415889-23-015446#line-2","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001898490","owner_name":"Farnum Rhonda","owner_display_name":"Farnum Rhonda","owner_url":"/insider/0001898490","role":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark":"O","role_mark_label":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, COMM & MEDICAL AFFAIRS","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1378.0,"shares_display":"1,378","price_per_share":10.29,"price_display":"10.29","price_state":"stated","total_value":14179.62,"total_display":"14,179.62","total_whole":"14,180","shares_owned_after":331206.0,"shares_owned_after_display":"331,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-21","filed_date":"2023-11-22","scope":"insider"},{"id":8710889,"accession":"0001415889-23-012621","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-012621","line_url":"/filing/0001415889-23-012621#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001898490","owner_name":"Farnum Rhonda","owner_display_name":"Farnum Rhonda","owner_url":"/insider/0001898490","role":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark":"O","role_mark_label":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, COMM & MEDICAL AFFAIRS","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1807.0,"shares_display":"1,807","price_per_share":9.47,"price_display":"9.47","price_state":"stated","total_value":17112.29,"total_display":"17,112.29","total_whole":"17,112","shares_owned_after":340566.0,"shares_owned_after_display":"340,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-22","filed_date":"2023-08-24","scope":"insider"},{"id":8479613,"accession":"0001415889-23-009636","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-009636","line_url":"/filing/0001415889-23-009636#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001898490","owner_name":"Farnum Rhonda","owner_display_name":"Farnum Rhonda","owner_url":"/insider/0001898490","role":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark":"O","role_mark_label":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, COMM & MEDICAL AFFAIRS","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1790.0,"shares_display":"1,790","price_per_share":11.13,"price_display":"11.13","price_state":"stated","total_value":19922.7,"total_display":"19,922.70","total_whole":"19,923","shares_owned_after":352833.0,"shares_owned_after_display":"352,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-12","scope":"insider"},{"id":8005788,"accession":"0001415889-23-004799","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-004799","line_url":"/filing/0001415889-23-004799#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001898490","owner_name":"Farnum Rhonda","owner_display_name":"Farnum Rhonda","owner_url":"/insider/0001898490","role":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark":"O","role_mark_label":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, COMM & MEDICAL AFFAIRS","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":10.2,"price_display":"10.20","price_state":"stated","total_value":40800.0,"total_display":"40,800.00","total_whole":"40,800","shares_owned_after":360190.0,"shares_owned_after_display":"360,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-09","filed_date":"2023-03-13","scope":"insider"},{"id":6867880,"accession":"0001415889-22-005627","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-005627","line_url":"/filing/0001415889-22-005627#line-2","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001898490","owner_name":"Farnum Rhonda","owner_display_name":"Farnum Rhonda","owner_url":"/insider/0001898490","role":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark":"O","role_mark_label":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, COMM & MEDICAL AFFAIRS","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1081.0,"shares_display":"1,081","price_per_share":8.93,"price_display":"8.93","price_state":"stated","total_value":9653.33,"total_display":"9,653.33","total_whole":"9,653","shares_owned_after":329990.0,"shares_owned_after_display":"329,990","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-05-24","scope":"insider"},{"id":6315200,"accession":"0001415889-22-002174","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-002174","line_url":"/filing/0001415889-22-002174#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001898490","owner_name":"Farnum Rhonda","owner_display_name":"Farnum Rhonda","owner_url":"/insider/0001898490","role":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark":"O","role_mark_label":"Officer (SVP, COMM & MEDICAL AFFAIRS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, COMM & MEDICAL AFFAIRS","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2356.0,"shares_display":"2,356","price_per_share":10.1641,"price_display":"10.16","price_state":"stated","total_value":23946.6196,"total_display":"23,946.62","total_whole":"23,947","shares_owned_after":333271.0,"shares_owned_after_display":"333,271","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001583107","name":"Theravance Biopharma, Inc.","url":"/issuer/0001583107","role":"Officer (SVP, COMM & MEDICAL AFFAIRS)","n_filings":16,"first_seen":"2022-03-02","last_seen":"2026-06-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001898490","retrieved_at":"2026-08-27T15:36:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}